{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:21:54Z","timestamp":1788384114565,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["20180540032"],"award-info":[{"award-number":["20180540032"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903463"],"award-info":[{"award-number":["81903463"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.bioorg.2020.104237","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T21:50:12Z","timestamp":1598478612000},"page":"104237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents"],"prefix":"10.1016","volume":"104","author":[{"given":"Shuang","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengbi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.104237_b0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2020.104237_b0010","doi-asserted-by":"crossref","unstructured":"C.T. Supuran, J.Y. Winum, Drug design of zinc-enzyme inhibitors: functional, structural, and disease applications, Wiley: Hoboken, NJ, 2009, Part II.","DOI":"10.1002\/9780470508169"},{"key":"10.1016\/j.bioorg.2020.104237_b0015","doi-asserted-by":"crossref","unstructured":"Y. Xu, L. Feng, P. D. Jeffrey P D, Y. Shi, F. M. M. Morel. Structure and metal exchange in the cadmium carbonic anhydrase of marine diatoms, Nature, 452 (2008) 56\u201361.","DOI":"10.1038\/nature06636"},{"key":"10.1016\/j.bioorg.2020.104237_b0020","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1517\/13543776.16.12.1627","article-title":"Carbonic anhydrase inhibitors and activators and their use in therapy","volume":"16","author":"Scozzafava","year":"2006","journal-title":"Expert Opin. Thera. Pat."},{"key":"#cr-split#-10.1016\/j.bioorg.2020.104237_b0025.1","doi-asserted-by":"crossref","unstructured":"C.T. Supuran, A. Scozzafava, J. Conway, Carbonic anhydrase-its inhibitors and activators, Boca Raton, 2004","DOI":"10.1201\/9780203475300"},{"key":"#cr-split#-10.1016\/j.bioorg.2020.104237_b0025.2","doi-asserted-by":"crossref","unstructured":"(c) C. T. Supuran, A. Scozzafava, A. Casini, Carbonic anhydrase inhibitors, Med. Res. Rev., 23 (2003) 146-189.","DOI":"10.1002\/med.10025"},{"key":"10.1016\/j.bioorg.2020.104237_b0030","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1574-6976.2000.tb00546.x","article-title":"Prokaryotic carbonic anhydrases","volume":"24","author":"Smith","year":"2000","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2020.104237_b0035","doi-asserted-by":"crossref","unstructured":"B. Zo\u0142nowska, J. S\u0142awinski, K. Szafranskia, A. Angeli, C. T. Supuran, A. Kawiak, M. Wieczor, J. Zielinska, T, Baczek, S. Bartoszewska, Novel 2-(2-arylmethylthio-4-chloro-5- methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies, 143 (2018) 1931\u20131941.","DOI":"10.1016\/j.ejmech.2017.11.005"},{"key":"10.1016\/j.bioorg.2020.104237_b0040","series-title":"Carbonic anhydrase: mechanism, regulation, links to disease, and industrial applications","author":"Susan","year":"2014"},{"key":"10.1016\/j.bioorg.2020.104237_b0045","first-page":"1637","article-title":"Progress in the study of carbonic anhydrase inhibitors as potential anticancer drugs","volume":"48","author":"Guo","year":"2013","journal-title":"Acta. Pharm. Sin."},{"key":"10.1016\/j.bioorg.2020.104237_b0050","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2020.104237_b0055","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2174\/138161208783877910","article-title":"Carbonic anhydrase as drug target","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm."},{"key":"10.1016\/j.bioorg.2020.104237_b0060","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1517\/13543776.2013.790957","article-title":"Antiobesity carbonic anhydrase inhibitors: a literature and patent review","volume":"23","author":"Scozzafava","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2020.104237_b0065","article-title":"Synthesis and biological evaluation of phloroglucinol derivatives possessing \u03b1-glycosidase, acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase inhibitory activity","volume":"1700314","author":"Burmaoglu","year":"2018","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.104237_b0070","first-page":"276","volume":"4","author":"Vullo","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0075","doi-asserted-by":"crossref","unstructured":"Cecchi, A. Hulikova, J. Pastorek, S. Pastorekova, C. T. Supuran, Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase ix that inhibit isozyme IX-mediated acidification of hypoxic tumors, J. Med. Chem., 48 (2005) 4834\u20134841.","DOI":"10.1021\/jm0501073"},{"key":"10.1016\/j.bioorg.2020.104237_b0080","doi-asserted-by":"crossref","first-page":"8512","DOI":"10.1021\/jm4009532","article-title":"Hypoxia-targeting carbonic anhydrase ix inhibitors by a new series of nitroimidazole-sulfonamides\/sulfamides\/sulfamates","volume":"56","author":"Rami","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18632\/oncotarget.422","article-title":"Recent developments in targeting carbonic anhydrase IX for cancer therapeutics","volume":"3","author":"McDonald","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.bioorg.2020.104237_b0090","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"Svastova","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bioorg.2020.104237_b0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1357-4310(99)01615-9","article-title":"Causes and consequences of tumor acidity and implications for treatment","volume":"6","author":"Stubbs","year":"2000","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.bioorg.2020.104237_b0100","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase ix and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14756366.2013.761876","article-title":"Carbonic anhydrases: from biomedical applications of the inhibitors and activators to biotechnologic use for CO2 capture","volume":"28","author":"Supuran","year":"2013","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0110","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/14756366.2012.672983","article-title":"Structure-based drug discovery of carbonic anhydrase inhibitors","volume":"27","author":"Supuran","year":"2012","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0115","doi-asserted-by":"crossref","unstructured":"W.M. Eldehna, G. H. Al-Ansary, S. Bua, A. Nocentini, P. Gratteri, Paola, A. Altoukhy, H. Ghabbour, H.Y. Ahmed, C.T. Supuran, Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: synthesis, in vitro, biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies. Eur. J. Med. Chem., 127 (2017) 521\u2013530.","DOI":"10.1016\/j.ejmech.2017.01.017"},{"key":"10.1016\/j.bioorg.2020.104237_b0120","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2020.104237_b0125","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0130","doi-asserted-by":"crossref","unstructured":"B. Zo1nowska, J. S1awinski, A. Pogorzelska, J. Chojnacki, D. Vullo, C. T. Supuran, Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N\u2019-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, Eur. J. Med. Chem., 71 (2014) 135\u2013147.","DOI":"10.1016\/j.ejmech.2013.10.081"},{"key":"10.1016\/j.bioorg.2020.104237_b0135","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104237_b0140","series-title":"Carbonic Anhydrase. Its Inhibitors and Activators","article-title":"Development of sulfonamide carbonic anhydrase inhibitors","author":"Supuran","year":"2004"},{"key":"10.1016\/j.bioorg.2020.104237_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.03.023","article-title":"Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site","volume":"132","author":"Hou","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2020.104237_b0150","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0155","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0968-0896(99)00190-X","article-title":"Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic\/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?","volume":"7","author":"Borras","year":"1999","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0160","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bmc.2013.11.016","article-title":"Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies","volume":"22","author":"Bozdag","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0165","series-title":"Looking towards the rim of the active site cavity of druggable human Carbonic Anhydrase isoforms","author":"Mancuso","year":"2020"},{"key":"10.1016\/j.bioorg.2020.104237_b0170","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.1021\/jm060967z","article-title":"A novel class of carbonic anhydrase Inhibitors: glycoconjuate benzene sulfonamides prepared by \u201cClick-Tailing\u201d","volume":"49","author":"Wilkinson","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0175","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.bmcl.2006.11.046","article-title":"Inhibition of membrane-associated carbonic anhydrase isozymes IX, XII and XIV with a library of glycoconjugate benzenesulfonamides","volume":"17","author":"Wilkinson","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104237_b0180","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/jm061320h","article-title":"Carbonic anhydrase Inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O- Glycosides of benzene sulfonamides","volume":"50","author":"Wilkinson","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0185","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2000","journal-title":"Exp. Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2020.104237_b0190","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.06.022","article-title":"Probing the \u2018bipolar\u2019 nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms","volume":"101","author":"Krasavin","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0195","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1016\/j.bmcl.2007.07.019","article-title":"Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides","volume":"17","author":"Smaine","year":"2007","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bioorg.2020.104237_b0200","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/jm200892s","article-title":"Targeting Hypoxic Tumor Cell Viability with Carbohydrate-Based Carbonic Anhydrase IX and XII Inhibitors","volume":"54","author":"Morris","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0205","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1021\/jm5012935","article-title":"Structural Insights into Carbonic Anhydrase IX Isoform Specificity of Carbohydrate-Based Sulfamates","volume":"57","author":"Moeker","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0210","doi-asserted-by":"crossref","first-page":"9623","DOI":"10.1021\/jm401163e","article-title":"A Prodrug Approach Toward Cancer-Related Carbonic Anhydrase Inhibition","volume":"56","author":"Carroux","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0215","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/jm701426t","article-title":"Inhibition of Carbonic Anhydrases with Glycosyltriazole Benzene Sulfonamides","volume":"51","author":"Wilkinson","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0220","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijbiomac.2019.03.019","article-title":"Synthesis, characterization and application of copper oxide chitosan nanocomposite for green regioselective synthesis of [1,2,3] triazoles","volume":"130","author":"Khalil","year":"2019","journal-title":"Int. J. of Biol. Macromol."},{"key":"10.1016\/j.bioorg.2020.104237_b0225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/17518253.2018.1474270","article-title":"Eco-friendly one-pot synthesis of some new pyrazolo[1,2-b] phthalazinediones with antiproliferative efficacy on human hepatic cancer cell lines","volume":"11","author":"Rashdan","year":"2018","journal-title":"Green Chem. Lett. Rev."},{"key":"10.1016\/j.bioorg.2020.104237_b0230","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/14756366.2019.1705293","article-title":"Design, synthesis and biological evaluation of carbohydrate-based sulphonamide derivatives as topical antiglaucoma agents through selective inhibition of carbonic anhydrase II","volume":"35","author":"Hou","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0235","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.bmc.2015.02.027","article-title":"A class of sulfonamide carbonic anhydrase inhibitors with neuropathic pain modulating effects","volume":"23","author":"Carta","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0240","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.carres.2009.05.022","article-title":"First total synthesis of 1,2-dipalmitoyl-3-(N-palmitoyl-60-amino-60-deoxy-a-D-glucosyl)-sn-glycerol-a glycoglycerolipid of a marine alga with a high inhibitor activity against human Myt1-kinase","volume":"344","author":"Gollner","year":"2009","journal-title":"Carbohyd. Res."},{"key":"10.1016\/j.bioorg.2020.104237_b0245","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.carres.2012.01.002","article-title":"Koenigs-Knorr reaction of fusel alcohols with methyl (1-bromo-2,3,4-tri-O-acetyl-a-D-glucopyranosid)uronate leading to the protected alkyl glucuronides-crystal structures and high resolution 1H and 13C NMR data","volume":"352","author":"M\u00f6nch","year":"2012","journal-title":"Carbohyd. Res."},{"key":"10.1016\/j.bioorg.2020.104237_b0250","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.bmc.2010.02.053","article-title":"Field, \u2018Click chemistry\u2019 synthesis of a library of 1,2,3-triazole-substituted galactose derivatives and their evaluation against Trypanosoma cruzi and its cell surface trans-sialidase","volume":"18","author":"Carvalho","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0255","article-title":"New selective carbonic anhydrase IX inhibitors: Synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides","volume":"1451\u20131464","author":"Florent","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104237_b0260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.bioorg.2020.104237_b0265","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1016\/S0021-9258(18)95800-X","article-title":"Anhydrases B and C Esterase activities of human carbonic enzymology","volume":"242","author":"Verpoorte","year":"1967","journal-title":"J. Biol. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820315340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820315340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:36:55Z","timestamp":1763566615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820315340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":54,"alternative-id":["S0045206820315340"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104237","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104237","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104237"}}